123 related articles for article (PubMed ID: 26260999)
1. Preparation, quality control and biodistribution assessment of ¹⁵³Sm-BPAMD as a novel agent for bone pain palliation therapy.
Rabie A; Enayati R; Yousefnia H; Jalilian AR; Shamsaei M; Zolghadri S; Bahrami-Samani A; Hosntalab M
Ann Nucl Med; 2015 Dec; 29(10):870-6. PubMed ID: 26260999
[TBL] [Abstract][Full Text] [Related]
2. Samarium-153-(4-[((bis (phosphonomethyl)) carbamoyl) methyl]-7,10-bis (carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl) acetic acid: A novel agent for bone pain palliation therapy.
Yousefnia H; Enayati R; Hosntalab M; Zolghadri S; Bahrami-Samani A
J Cancer Res Ther; 2016; 12(3):1117-1123. PubMed ID: 28054521
[TBL] [Abstract][Full Text] [Related]
3. Estimated human absorbed dose of a new (153)Sm bone seeking agent based on biodistribution data in mice: Comparison with (153)Sm-EDTMP.
Yousefnia H; Zolghadri S
Phys Med; 2015 Nov; 31(7):714-9. PubMed ID: 26095757
[TBL] [Abstract][Full Text] [Related]
4. Production, quality control, biodistribution assessment and preliminary dose evaluation of (177)Lu-PDTMP as a possible bone palliative agent.
Yousefnia H; Jalilian AR; Zolghadri S; Ghannadi-Maragheh M
Nucl Med Commun; 2014 Jan; 35(1):99-107. PubMed ID: 24162837
[TBL] [Abstract][Full Text] [Related]
5. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
[TBL] [Abstract][Full Text] [Related]
6. (170)Tm-EDTMP: a potential cost-effective alternative to (89)SrCl(2) for bone pain palliation.
Das T; Chakraborty S; Sarma HD; Tandon P; Banerjee S; Venkatesh M; Pillai MR
Nucl Med Biol; 2009 Jul; 36(5):561-8. PubMed ID: 19520297
[TBL] [Abstract][Full Text] [Related]
7. Syntheses and evaluation of
Chakraborty S; Goswami D; Chakravarty R; Mohammed SK; Sarma HD; Dash A
Chem Biol Drug Des; 2018 Sep; 92(3):1618-1626. PubMed ID: 29729071
[TBL] [Abstract][Full Text] [Related]
8. Ethylene diamine tetramethylene phosphonic acid labeled with various β(-)-emitting radiometals: labeling optimization and animal biodistribution.
Sohaib M; Ahmad M; Jehangir M; Perveen A
Cancer Biother Radiopharm; 2011 Apr; 26(2):159-64. PubMed ID: 21510750
[TBL] [Abstract][Full Text] [Related]
9. Production and quality control 177Lu (NCA)-DOTMP as a potential agent for bone pain palliation.
Salek N; Shamsaei M; Ghannadi Maragheh M; Shirvani Arani S; Bahrami Samani A
J Appl Clin Med Phys; 2016 Nov; 17(6):128-139. PubMed ID: 27929488
[TBL] [Abstract][Full Text] [Related]
10. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S
Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337
[TBL] [Abstract][Full Text] [Related]
11. Human absorbed dose estimation for a new (175)Yb-phosphonate based on rats data: Comparison with similar bone pain palliation agents.
Vaez-Tehrani M; Zolghadri S; Yousefnia H; Afarideh H
Appl Radiat Isot; 2016 Sep; 115():55-60. PubMed ID: 27337650
[TBL] [Abstract][Full Text] [Related]
12. A DOTA based bisphosphonate with an albumin binding moiety for delayed body clearance for bone targeting.
Meckel M; Kubíček V; Hermann P; Miederer M; Rösch F
Nucl Med Biol; 2016 Nov; 43(11):670-678. PubMed ID: 27560354
[TBL] [Abstract][Full Text] [Related]
13. Preparation and biological evaluation of 153Sm-DOTMP as a potential agent for bone pain palliation.
Chakraborty S; Das T; Banerjee S; Chaudhari PR; Sarma HD; Venkatesh M; Pillai MR
Nucl Med Commun; 2004 Dec; 25(12):1169-76. PubMed ID: 15640774
[TBL] [Abstract][Full Text] [Related]
14. 13- and 14-membered macrocyclic ligands containing methylcarboxylate or methylphosphonate pendant arms: chemical and biological evaluation of their (153)Sm and (166)Ho complexes as potential agents for therapy or bone pain palliation.
Marques F; Gano L; Paula Campello M; Lacerda S; Santos I; Lima LM; Costa J; Antunes P; Delgado R
J Inorg Biochem; 2006 Feb; 100(2):270-80. PubMed ID: 16387365
[TBL] [Abstract][Full Text] [Related]
15. Preliminary studies on (177)Lu-labeled sodium pyrophosphate (177Lu-PYP) as a potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2012 Aug; 39(6):763-9. PubMed ID: 22459337
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
Suzuki K; Satake M; Suwada J; Oshikiri S; Ashino H; Dozono H; Hino A; Kasahara H; Minamizawa T
Nucl Med Biol; 2011 Oct; 38(7):1011-8. PubMed ID: 21982572
[TBL] [Abstract][Full Text] [Related]
17. A bisphosphonate monoamide analogue of DOTA: a potential agent for bone targeting.
Kubícek V; Rudovský J; Kotek J; Hermann P; Vander Elst L; Muller RN; Kolar ZI; Wolterbeek HT; Peters JA; Lukes I
J Am Chem Soc; 2005 Nov; 127(47):16477-85. PubMed ID: 16305234
[TBL] [Abstract][Full Text] [Related]
18. Rhemium-186-monoaminemonoamidedithiol-conjugated bisphosphonate derivatives for bone pain palliation.
Ogawa K; Mukai T; Arano Y; Otaka A; Ueda M; Uehara T; Magata Y; Hashimoto K; Saji H
Nucl Med Biol; 2006 May; 33(4):513-20. PubMed ID: 16720243
[TBL] [Abstract][Full Text] [Related]
19. Estimated human absorbed dose of ¹⁷⁷Lu-BPAMD based on mice data: Comparison with ¹⁷⁷Lu-EDTMP.
Yousefnia H; Zolghadri S; Shanehsazzadeh S
Appl Radiat Isot; 2015 Oct; 104():128-35. PubMed ID: 26163291
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
